Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NovoTTFTM-100A System Therapy for Refractory CNS Involved Small Cell Lung Cancer

NCT02425072 is registered in ClinicalTrials.gov with John Villano as lead sponsor.

NCT NCT02425072
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02425072 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NovoTTFTM-100A System Therapy for Refractory CNS Involved Small Cell Lung Cancer
Lead sponsor
John Villano
Phase
Phase 2
Overall status
Withdrawn
Start date
April 30, 2016
Completion date
July 31, 2022
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain metastasis, small cell lung cancer